That the House of Representatives— (1) affirms the United States continued support for the purchase of vaccines for developing countries through the GAVI Alliance as a cost-effective, efficient means to reduce mortality and as a critical component of meeting the United States goal to end preventable maternal and child deaths; (2) supports the principles and goals of the GAVI Alliance to— (A) introduce and scale up immunization; (B) improve sustainability of immunization programs; (C) ensure healthy markets for vaccines and related products; and (D) strengthen health systems to increase equity in immunization; (3) recognizes that the United States Government support to the GAVI Alliance is a critical component to ensuring health security in the United States; (4) encourages the continued use of United States Agency for International Development maternal and child health and Centers for Disease Control and Prevention global immunization resources to strengthen local public health capacity to introduce and sustain new and underutilized vaccines, that are supported by the GAVI Alliance, through routine immunization systems; (5) recognizes the need for multiyear pledges from the United States to allow GAVI to maximize its impact to provide lifesaving vaccines and to leverage contributions from other countries and donors; and (6) encourages continued commitment and investment at least at the current appropriated funding level by the United States Government to the GAVI Alliance in the 2021–2025 GAVI Alliance strategic period in order to ensure that lives are protected and saved through access to vaccines and immunizations.